Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Tretinoin · Altreno, Retin-A Micro

Small molecule · Agonist of retinoic acid receptor alpha (RARA), retinoic acid receptor beta (RARB) and retinoic acid receptor gamma (RARG) · developed by Bausch

Approved FDA, Jul 1974
1 Registered trials

What is Tretinoin?

Tretinoin is a metabolite of vitamin A that binds retinoic acid receptors RARα, RARβ and RARγ in the cytosol and nucleus, modifying gene expression and epithelial cell growth and differentiation. It is applied topically to reduce follicular epithelial cohesiveness and comedone formation in acne vulgaris.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Altreno, Retin-A Micro, Tretinoin Cream, NSC-122758
Drug type
Small molecule
Targets
retinoic acid receptor alpha (RARA), retinoic acid receptor beta (RARB), retinoic acid receptor gamma (RARG)
Mechanism
Agonist of retinoic acid receptor alpha (RARA), retinoic acid receptor beta (RARB) and retinoic acid receptor gamma (RARG)
Pathways
gene expression regulation, epithelial cell differentiation and growth, follicular epithelial cell turnover
Therapy area
Dermatology
Developer
Bausch
In trials of
SLGL
FDA status
Approved as Altreno, Retin-A Micro, Tretinoin Cream (July 19, 1974), NDA017522 · FDA label
UNII
5688UTC01R

✅ FDA-approved uses

From the indications section of the FDA label (version of Oct 14, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT04059523 Phase 1 Acne Vulgaris Completed SLGL

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Acne Vulgaris

Other drugs acting on RARA / RARB / RARG

Sources

Updated Nov 22, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.